The new site will be used for the storage of contingency stocks of European Pharmacopoeia reference standards for distribution worldwide in case of major incidents at its main site in Strasbourg, France.
European Directorate for the Quality of Medicines (EDQM) opened a secondary site in Ars-Laquenexy, France, on Nov. 15, 2019 for the storage of contingency stocks of European Pharmacopoeia reference standards for distribution worldwide in case of major incidents at its main site in Strasbourg, France.
According to a company press release, the new site is part of EDQM’s goal to create a full backup stock of European Pharmacopoeia reference standards in order to combat a potential supply shortage, which would result in the blockage of certain medicines from European and non-European markets. In 2018, over 1.6 million vials of reference standards were produced to build up the stock for the new site.
The new site has 2770 m2 of floor area with designated space for preparation of samples required for laboratory studies carried out during the development of monographs and the establishment of reference standards, according to the release. The space also has the storage capacity for 9.4 million vials and 378 pallets.
“The reference standards produced by the EDQM are fundamental to guarantee that all patients in Europe and beyond have uninterrupted access to the good-quality medicines they need,” said SnezÌana SamardzÌicÌ-MarkovicÌ, director general of democracy of the Council of Europe, in the press release.
Source:
EDQM
Drug Solutions Podcast: Gliding Through the Ins and Outs of the Pharma Supply Chain
November 14th 2023In this episode of the Drug Solutions podcast, Jill Murphy, former editor, speaks with Bourji Mourad, partnership director at ThermoSafe, about the supply chain in the pharmaceutical industry, specifically related to packaging, pharma air freight, and the pressure on suppliers with post-COVID-19 changes on delivery.
Drug Solutions Podcast: Emerging Methods of Vaccine Administration and Distribution
June 20th 2023Michael Schrader, CEO and co-founder of Vaxess, discusses the latest on vaccine administration and different ways the pharmaceutical industry can distribute these products with Pharmaceutical Technology editor Jill Murphy.